Fierce Pharma

AUGUST 5, 2024

Join us at Digital Pharma East 2024 on Sept. The pharmaceutical industry is in a constant state of evolution, driven by technological advancements, shifting consumer behaviors, and a complex regulatory landscape. 9-12 in Philadelphia to learn, connect, and innovate with your life sciences marketing industry peers.

Pharma 187

Pharma Marketing Pharmaceutical 187

Fierce Pharma

SEPTEMBER 27, 2024

Gilead Sciences' Kite will bow out of its China joint venture with Fosun Pharma. Gilead's Kite will bow out of its China joint venture with Fosun Pharma. AstraZeneca and Daiichi Sankyo's Dato-DXd failed to improve survival in a breast cancer study.

Pharma 242

Pharma 242

Fierce Pharma

SEPTEMBER 19, 2024

In this week's episode of "The Top Line," we’re recapping and discussing the major trends from Digitial Pharma East, w | In this week's episode of "The Top Line," we’re recapping and discussing the major trends from Digitial Pharma East.

Pharma 130

Pharma 130

Fierce Pharma

JULY 19, 2024

A 10-page Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind a recent FDA rejection. A 10-observation Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind its recent FDA rejection. Singapore biotech Aslan Pharma is winding down. And more.

Pharma 245

Pharma FDA 245

Fierce Pharma

JULY 9, 2024

Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team, shaking up its structure, personnel and operations. Bayer’s massive reorganization championed by CEO Bill Anderson is bringing major changes to the German company’s pharma commercial team.

Pharma 280

Pharma 280

Fierce Pharma

NOVEMBER 20, 2023

“AI is becoming part of the pharma fabric, and it really is set to disrupt the industry.” | Viz.ai’s Nina Binetti is joined by colleagues at CrowdPharm and Remedy Product Studio to explore the various ways in which AI is being used among pharma companies – from improving patient diagnoses and treatments to unlocking operating efficiencies.

Pharma 283

Pharma Patients 283

Fierce Pharma

OCTOBER 3, 2024

On the same day as Roche's Pharma Day in London, the biopharma giant revealed a high-dollar deal with Chinese-American biotech Regor for the latter's CDK inhibitors. |

Pharma 245

Pharma Biopharma Sales 245

Fierce Pharma

JULY 22, 2024

Grünenthal has continued its expansion splurge, | Grünenthal has continued its expansion splurge, acquiring Valinor Pharma and its lone commercial product Movantik (naloxegol), a treatment for opioid-induced constipation (OIC), for $250 million.

Pharma 263

Pharma 263

Fierce Pharma

OCTOBER 1, 2024

Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of | Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today.

Pharma 130

Pharma Marketing 130

Fierce Pharma

OCTOBER 11, 2023

Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Learn more by watching the videos below.

Pharma 245

Pharma Marketing 245

Fierce Pharma

JULY 19, 2024

While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown | While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at (..)

Pharma 280

Pharma 280

Fierce Pharma

SEPTEMBER 13, 2024

Another study showed that Pharma&’s attempt to enhance its Rubraca with Bristol Myers Squibb’s Opdivo seriously backfired. . | In a rough day for PARP inhibitors in ovarian cancer, GSK’s Zejula didn’t deliver a life extension benefit in the final analysis of a phase 3 trial.

Pharma 283

Pharma 283

Fierce Pharma

MAY 28, 2024

Since NS Pharma launched its Duchenne muscular dystrophy (DMD) drug Viltepso (viltolarsen) in 2020, sales have steadily

Pharma 259

Pharma Sales 259

Fierce Pharma

NOVEMBER 28, 2023

Gilead Sciences' Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce. Gilead’s Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce.

Pharma 322

Pharma 322

Fierce Pharma

OCTOBER 9, 2023

Marketers operating in every sector are seeking ways to offer personalized, high-quality experiences to their target audiences. | How much influence will AI exert over pharma marketing? Fingerpaint Group’s Paul Hagopian sits down with Fierce Pharma to discuss what has become a hotly contested topic.

Marketing 246

Marketing Pharma 246

Fierce Pharma

SEPTEMBER 20, 2024

Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA manufacturing observations aliu Fri, 09/20/2024 - 09:21

Manufacturing 227

Manufacturing Pharma FDA 227

Fierce Pharma

NOVEMBER 20, 2023

s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. s drug pricing policy, the pharma industry has secured an improved government spending deal. After blasting the U.K.’s After blasting the U.K.’s

Government 297

Government Pharma Prescription 297

Fierce Pharma

DECEMBER 21, 2023

Big Pharma companies have often talked about the major opportunities that await in China. | Big Pharma companies have often talked about the major opportunities that await in China. But as price cuts play out and internal priorities shift, multinational companies are reworking their business models in the country.

Pharma 301

Pharma 301

Fierce Pharma

MAY 3, 2024

Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. | Leo Pharma's delgocitinib, which the company calls a potential growth driver, could shake up the topical JAK market and put pressure on Incyte's approved Opzelura.

Marketing 270

Marketing Pharma 270

Fierce Pharma

OCTOBER 11, 2024

AstraZeneca has bagged a cardiovascular disease candidate from China's CSPC Pharma in a deal potentially worth $2 billion. AstraZeneca has bagged a cardiovascular disease candidate from China's CSPC Pharma in a deal potentially worth $2 billion.

Pharma 140

Pharma 140

Fierce Pharma

JUNE 13, 2024

Through a licensing deal with a Chinese biotech, AbbVie is the latest Big Pharma to bet on TL1A in immunology. Through a deal with a Chinese biotech, AbbVie is the latest Big Pharma to bet on TL1A in immunology. A former Takeda employee has pleaded guilty to scamming the Japanese drugmaker.

Pharma 242

Pharma 242

Fierce Pharma

DECEMBER 20, 2023

Following an IPO and ahead of its fiscal 2023 earnings release next month, German drug containment and delivery specialist Schott Pharma is trumpeting its recent momentum. | Following an IPO and ahead of its fiscal 2023 earnings release next month, pharma glass specialist Schott Pharma is trumpeting its recent momentum.

Pharma 250

Pharma Sales 250

Fierce Pharma

OCTOBER 3, 2024

Omnichannel marketing has proven itself as a powerful strategy across industries, and healthcare and pharma are no excep | In this insightful episode, we sit down with Jaclene Johnson, Vice President at Tandem, a leading precision healthcare marketing technology firm, to explore how omnichannel can be effectively harnessed by professionals in the healthcare (..)

Pharma 130

Pharma Healthcare Healthcare Marketing 130

Fierce Pharma

OCTOBER 1, 2024

As the landscape of healthcare advertising evolves, how can brands effectively reach their audiences while ensuring da | Fierce Pharma’s Michelle Benz sought to find the answer to this pressing question, sitting down with Mallory Wils, EVP of Sales for healthcare data science advertising specialist BranchLab, during Digital Pharma East 2024.

Pharma 130

Pharma Marketing Healthcare Healthcare 130

Fierce Pharma

OCTOBER 1, 2024

As digital advertising continues to evolve, Connected TV (CTV) and Over-the-Top (OTT) platforms remain essential for re | The world of pharma marketing is no exception to this. In today’s industry, professionals are tasked with managing the use of digital mediums alongside traditional media channels to create a cohesive marketing strategy.

Media 130

Media Marketing Pharma Management 130

Fierce Pharma

OCTOBER 13, 2023

Back in February, Leo Pharma revealed that its JAK-inhibitor cream delgocitinib met its primary and secondary endpoints in a phase 3 trial in chronic hand eczema, putting pressure on Incyte’s appro | Back in February, Leo Pharma revealed that its JAK-inhibitor cream delgocitinib met its primary and secondary endpoints in a phase 3 trial in chronic (..)

Pharma 281

Pharma 281

Fierce Pharma

MARCH 20, 2024

In the pharma sector, Bayer revealed a new Global Commercialization unit, which will be led by Christine Roth. .” | Early this month at an investor event, Bayer CEO Bill Anderson declared that employees “are ready for change." " On Wednesday, Anderson answered the call with changes to the company’s leadership.

Pharma 266

Pharma 266

Fierce Pharma

MARCH 28, 2024

Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. AstraZeneca is working to separate its supply chains for the U.S. AstraZeneca is working to separate its supply chains for the U.S. and China.

Pharma 130

Pharma Marketing 130

Fierce Pharma

OCTOBER 3, 2024

I will too,” said Steven Carickhoff, president of BioPharm Communications, at Digital Pharma East. | “I’m sure if you were to sit anybody else in this chair, they lead with AI.

Pharma 130

Pharma Marketing Leads 130

Fierce Pharma

MAY 29, 2024

Tris Pharma has won FDA approval for Onyda XR (clonidine hydrochloride). Stimulants are typically the go-to option for doctors prescribing treatments for attention-deficit hyperactivity disorder (ADHD).

Pharma 227

Pharma FDA Doctors Medical 227

Fierce Pharma

APRIL 25, 2024

Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Staff Writer Kevin Dunleavy are diving into our annual top pharma companies by revenue special report.

Pharma 130

Pharma Specialization 130

Fierce Pharma

MARCH 21, 2024

Three large pharma companies plan to expand their manufacturing footprints. Three large pharma companies plan to expand their manufacturing footprints. Kyowa Kirin’s $4.25 million gene therapy set a new world pricing record. Kyowa Kirin’s $4.25 million gene therapy set a new world pricing record.

Pharma 246

Pharma Manufacturing FDA 246

World of DTC Marketing

AUGUST 15, 2022

The great resignation has not affected pharma because the jobs within the industry pay very well and most positions and employees like the benefit of having a steady job with good money. However, some pharma companies are having problems filling open positions, and when they do, they often find it wasn’t a good fit.

Pharma 281

Pharma Management Marketing 281

Fierce Pharma

SEPTEMBER 27, 2023

Will Big Pharma engage in Medicare price negotiations? The verdict's not in zbecker Wed, 09/27/2023 - 10:40

Pharma 303

Pharma 303

MedCity News

OCTOBER 9, 2024

If you thought that Big Pharma and the PBMs were the only bad guys in the saga of unreasonably high prescription drug prices in the United States, you would be wrong. The post Video: Besides, Pharma and PBMs, Who Drives Up Drug Costs? Hear who else is to blame from the CEO of Blue Shield of California.

Pharma 124

Pharma Prescription 124

MedCity News

OCTOBER 21, 2024

The post Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer appeared first on MedCity News. The FDA approved Astellas’s Vyloy as a treatment for advanced cases of gastric or gastroesophageal junction (GEJ) adenocarcinoma positive for a protein called claudin 18.2.

Pharma 117

Pharma FDA Biopharma 117

Fierce Pharma

JANUARY 23, 2024

Ahead of key Stelara patent cliff, J&J's pharma business churns out growth fkansteiner Tue, 01/23/2024 - 11:32

Pharma 246

Pharma 246